Objective assessment criterion for intensity of destructive processes in chronic dermatoses (part 1)

E A Korotkaya , S G Morozov , E N Volkova , N K Osipova , M L Esimbieva , I V Elistratova , Е А Korotkaya , S G Morozov , E N Volkova , N K Osipova , M L Esimbieva , I V Elistratova

Russian Journal of Skin and Venereal Diseases ›› 2011, Vol. 14 ›› Issue (3) : 32 -36.

PDF
Russian Journal of Skin and Venereal Diseases ›› 2011, Vol. 14 ›› Issue (3) : 32 -36. DOI: 10.17816/dv36565
Articles
other

Objective assessment criterion for intensity of destructive processes in chronic dermatoses (part 1)

Author information +
History +
PDF

Abstract

Authors present an algorithm of examination of immunologic parameters in patients with chronic dermatoses. This examination is based on evaluation of leukocytic elastase activity and allows to assess the severity of destructive processes as well as intensity of compensatory antidestructive potential.

Keywords

acne / activity of destructive processes / leukocytic elastase / α1-proteinase inhibitor

Cite this article

Download citation ▾
E A Korotkaya, S G Morozov, E N Volkova, N K Osipova, M L Esimbieva, I V Elistratova, Е А Korotkaya, S G Morozov, E N Volkova, N K Osipova, M L Esimbieva, I V Elistratova. Objective assessment criterion for intensity of destructive processes in chronic dermatoses (part 1). Russian Journal of Skin and Venereal Diseases, 2011, 14(3): 32-36 DOI:10.17816/dv36565

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Доценко В. Л., Нешкова Е. А., Яровая Г. А. // Вопр. мед. химии. - 1994. - Т. 40, № 3. - С. 20-25.

[2]

Нешкова Е. А., Доценко В. Л., Ларионов Н. И., Яровая Г. А. // Биохимия. - 1993. - Т. 58. - С. 1886-1892.

[3]

Albani D., Balduyck M., Mizon J. // J. Lab. Clin. Med. - 1997. - Vol. 130. - P. 339-347.

[4]

Beatty K., Bieth J. G., Travis J. // J. Biol. Chem. - 1980. - Vol. 255. - P. 3931-3934.

[5]

Bieth J. G. // Regulating of Matrix Accumulation / Ed. R. P. Mecham. - New York: Acad. Press; 1986. - P. 217-320.

[6]

Billing A. G., Jochum M., Frohlich D. et al. // Eur. J. Clin. Invest. - 1997. - Vol. 27. - P. 1030-1037.

[7]

Bogdanova M., Domazetovska S., Gruev T., Polenokovic B. 12th European Congress of Clinical Chemistry, Basel, Switzerland. - 1997. - Abstr. 286.

[8]

Braun N. J., Bodmer J. L., Virca G. D. et al. // Biol. Chem. Hoppe Seyler. - 1987. - Vol. 368, N 4. - P. 299-308.

[9]

Brightbill H. D., Libraty D. H., Krutzik S. R. et al. // Science. - 1999. - Vol. 285, N 5428. - P. 732-736.

[10]

Burkhardt H., Kasten M., Rauls S., Renkopf E. // Reumatol. Int. - 1987. - Vol. 7, N 4. - P. 133-138.

[11]

Burkhart C. G., Burkhart C. N., Lehmann P. F. // Postgrad. Med. J. - 1999. - Vol. 75, N 884. - P. 328-331.

[12]

Chen Q., Koga T., Uchi H. et al. // J. Dermatol. Sci. - 2002. - Vol. 29, N 2. - P. 97-103.

[13]

Chignard M., Balloy V., Renesto P. // Eur. Respir. J. - 1993. - Vol. 6. - P. 791-796.

[14]

Chow J. C., Young D. W., Golenbock D. T. et al. // J. Biol. Chem. - 1999. - Vol. 274. - P. 10689-10692.

[15]

Dittmann B., Steger A., Wimmer R., Fritz H. // Hoppe-Seylers Z. Physiol. Chem. - 1981. - Bd 362, N 7. - S. 919-927.

[16]

Fourrier F. // Blood Coagul. Fibrinolysis. - 1998. - Suppl. 2. -P. S39-S45.

[17]

Frommherz K. J., Faller B., Bieth J. G. // J. Biol. Chem. - 1991. - Vol. 266. - P. 15356-15362.

[18]

Hoeffler U., Ko H. L., Pulverer G. // Antimicrob. Agents Chemother. - 1976. - Vol. 10. - P. 387-394.

[19]

Hornebeck W., Schnebli H. P. // Hoppe-Seylers Z. Physiol. Chem. - 1982. - Bd 363, N 4. - S. 455-458.

[20]

Hoshino K., Takeuchi O., Kawai T. et al. // J. Immunol. - 1999. - Vol. 162. - P. 3749-3752.

[21]

Jochum M., Fritz H. // Immune Consequences of Trauma, Shock, and Sepsis / Eds. E. Faist et al. Berlin; Heidelberg: Springer-Verlag; 1989. - P. 165-172.

[22]

Jochum M., Machleidt W., Fritz H. // Handbook of Mediators in Septic Shock / Eds E. Neugebauer, J. W. Holaday. - London; Tokyo: CRC Press/ Boca Baton; 1993. - P. 335-362.

[23]

Jung Y. S., Matsumoto S. E., Yamashita M. et al. // Biosci. Biotechnol. Biochem. - 2007. - Vol. 71. - P. 1963-1969.

[24]

Kersey P., Sussman M., Dahl M. // Br. J. Dermatol. - 1980. - Vol. 103. - P. 651-655.

[25]

Kim J., Ochoa M. T., Krutzik S. R. et al. // J. Immunol. - 2002. - Vol. 169. - P. 1535-1541.

[26]

Laemmli U. K. // Nature. - 1970. - Vol. 227. - P. 680-685.

[27]

Machovich R., Owen W. G. // Blood Coagul. Fibrinolysis. - 1990. - Vol. 1. - P. 79-84.

[28]

Medzhitov R., Janeway C. // Trends Microbiol. - 2000. - Vol. 8. - P. 452-456.

[29]

Mythen M. G., Barelay G. R., Purdy G. et al. // Blood Coagul. Fibrinolysis. - 1993. - Vol. 4. - P. 999-1005.

[30]

Ohlsson K. // Neutral Proteases of Human Polymorphonuclear Leukocytes / Eds. K. Havemann, A. Janoff. - 1978. - P. 167- 177.

[31]

Owen C. A., Campbell M. A., Sannes Ph. L. et al. // J. Cell Biol. - 1995. - Vol. 131. - P. 775-789.

[32]

Towbin H., Staechlin T., Gordon J. // Proc. Natl. Acad. Sci. USA. - 1979. - Vol. 76, N 9. - P. 4340-4344.

[33]

Tsujii T., Katajama K., Naito I., Seno S. // Histochemistry. - 1988. - Vol. 88. - P. 443-451.

[34]

Vogelmeier C., Biedermann T., Maier K. et al. // Eur. Respir. J. - 1997. - Vol. 10. - P. 2114-2119.

[35]

Weiss S. J. // N. Engl. J. Med. - 1989. - Vol. 320. - P. 365- 376.

[36]

Yamanouchi H., Fujita J., Hojo S. et al. // Eur. Respir. J. - 1998. - Vol. 11, N 1. - P. 120-125.

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

153

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/